TG Therapeutics | TGTX - Ebitda


TG Therapeutics reported $51.69M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
AbbVie USD 5.37B 1.85B Dec/2025
Alaunos Therapeutics USD -21.02M 1.33M Mar/2021
Amgen USD 5.14B 775M Dec/2025
Ardelyx USD 6.02M 447K Dec/2025
Arrowhead Research USD 57.17M 7.03M Dec/2025
Bayer EUR 4.45B 2.49B Mar/2026
Biogen USD 649.7M 76.5M Mar/2026
Corcept Therapeutics USD 4.2M 6.5M Dec/2025
Curis USD -12.3M 231K Sep/2023
Gilead Sciences USD 3.02B 1.01B Dec/2025
Infinity Pharmaceuticals USD -10.01M 1.39M Jun/2023
J&J USD 7.19B 2.32B Dec/2025
Karyopharm Therapeutics USD -26.2M 1.83M Sep/2024
Novartis USD 5.3B 530M Mar/2026
Novavax USD 19.36M 190.79M Dec/2025
PTC Therapeutics USD -70.99M 91.62M Dec/2025
Puma Biotechnology USD 729K 11.36M Jun/2024
Regeneron Pharmaceuticals USD 1.2B 718.4M Dec/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
TG Therapeutics USD 51.69M 19M Dec/2025
Vertex Pharmaceuticals USD 1.19B 195.3M Mar/2026